drugset / Trial / NCT02934204
Temozolomide in Treatment of Patients With Primary Central Nervous System Lymphoma
NaSingle-groupOpen-labelTreatment
Summary
Consolidation treatment for Primary Central Nervous System Diffuse Large B cell Lymphoma(PCNSL)patients remains to be defined.Here we designed a tolerated treatment of HDMTX plus Temozolomide,followed by consolidation with Temozolomide in PCNSL patients.
Timeline
- Start
- 2016-02
- Primary completion
- 2019-02
- Completion
- 2019-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methotrexate | Small molecule | 3.5 g | Intravenous |
| Subject | Temozolomide | Small molecule | 150 mg/m2 | Oral |